Sort
17,288 grants matching “multiple sclerosis”
CHARACTERIZATION OF PHOTOOXIDIZED PLASMENYLCHOLINES
$34,600Purdue University West Lafayette · R03 · FY2002 · TW
The Annual Blood-Brain Barrier Consortium Meeting
$34,565Edward A Neuwelt · Oregon Health & Science University · R13 · FY2009 · CA
OPEN LABEL PROTOCOL TO ASSESS STEADY STATE PHARMACOKINETICS OF FAMPRIDINE
$34,535Yale University · M01 · FY2000 · RR
OPEN LABEL DOSE PROPORTIONALITY--ASSESS SAFETY/TOLERABILITY OF FAMPRIDINE (4AP)
$34,535Yale University · M01 · FY2000 · RR
MULTIPLE SCLEROSIS COPOLYMER 1 (COPAXONE)
$34,535Yale University · M01 · FY2000 · RR
EVALUATE EFFICACY OF AVONEX FOR MULTIPLE SCLEROSIS TREATMENT
$34,535Yale University · M01 · FY2000 · RR
PHASE III SAFETY AND EFFICACY EVALUATION OF BETASERON IN MULTIPLE SCLEROSIS
$34,535Yale University · M01 · FY2000 · RR
LEUSTATIN (CLADRIBINE) CLINICAL TRIAL IN CHRONIC PROGRESSIVE MS
$34,535Yale University · M01 · FY2000 · RR
TOLERABILITY OF AVONEX (INTERFERON BETA 1A) IN TREATMENT OF MULTIPLE SCLEROSIS
$34,535Yale University · M01 · FY2000 · RR
TRIAL OF INTERFERON BETA 1A IN TREATMENT OF SUBJECTS WITH HIGH RISK FOR MS
$34,535Yale University · M01 · FY2000 · RR
MECHANISMS OF NEURODEGENERATION AND STRATEGIES FOR NEUROPROTECTION IN MS
$34,526Peter A Calabresi · Hugo W. Moser Res Inst Kennedy Krieger · P41 · FY2007 · RR
Neuronal activity-dependent intracellular calcium signaling regulates oligodendrocyte maturation
$34,519Michael A Thornton · University Of Colorado Denver · F31 · FY2022 · NS
Single-Cell Analysis of Somatic Mutation Rates, Mechanisms, and Impacts in Human Ataxia Telangiectasia Cerebellum
$34,454Bradley Class · Univ Of Massachusetts Med Sch Worcester · F31 · FY2025 · NS
Diversity Supplement Hope - Parent Grant: HD079009 - Dose-Response Effects of Whole Body Vibration on Spasticity and Walking in SCI
$34,400Edelle Carmen Field-Fote · Shepherd Center · R01 · FY2018 · HD
Intracellular Target of Sphingosine-1-Phosphate
$34,387Graham M Strub · Virginia Commonwealth University · F30 · FY2009 · NS
Intestinal Dysmotility in Multiple Sclerosis
$34,373Estelle Spear Bishop · University Of Vermont & St Agric College · F31 · FY2016 · DK
Multimodal Imaging of TBRII-Driven Phenotypes in Mouse Models of Osteoarthritis
$34,339Joseph D Temple · Univ Of North Carolina Chapel Hill · F31 · FY2016 · AG
Interrogating immune signatures in the thoracic duct of patients with multiple sclerosis
$34,290Diego Alexander Espinoza · University Of Pennsylvania · F31 · FY2022 · AI
Characterizing the role of migration, proliferation, and contact-mediated repulsion in oligodendrocyte progenitor cell tiling
$34,277Maria Ali · University Of Virginia · F31 · FY2019 · NS
Intra-Lymph Node Delivery of Tolerogenic Microparticles for Modulating Disease in a Model of Multiple Sclerosis
$34,274Emily A Gosselin · Univ Of Maryland, College Park · F31 · FY2019 · AI
Intracellular Target of Sphingosine-1-Phosphate
$34,099Graham M Strub · Virginia Commonwealth University · F30 · FY2010 · NS
Effects of Physical Activity on Cognition in Persons with Multiple Sclerosis
$34,097Janet D. Morrison · University Of Texas At Austin · F31 · FY2015 · NR
Modulation of sensory representations in the auditory cortex by callosal inputs
$34,078Bernard Slater · Duke University · F32 · FY2020 · DC
Sodium Chloride Induced Dysregulation of CD4+CD25+ Regulatory T Cells in Patients
$34,029Amanda Hernandez · Yale University · F31 · FY2014 · NS
Investigating a novel role of DRAK2 in T cell migration and synapse formation
$34,020Benjamin Andrew Wilander · St. Jude Children'S Research Hospital Graduate School Of Biomedical Sciences, Llc · F31 · FY2023 · AI